In Ukraine, clinical trials of Pfizer and Merck tablets against the coronavirus are starting. They will be tested on the basis of the student hospital in Kharkiv. This was reported by the press service of the Ministry of Health.
So in Ukraine they will test the drug "Ritonavir" produced by Pfizer in tablets of 150 mg. Persons who have been in contact with patients with COVID-19 will participate in clinical studies.
Tests of tablets MK4482-013 "Molnupinavir" produced by Merck were also approved. Adults who live with patients with COVID-19 will take part in them.
Note that the Pfizer company stated that their experimental PAXLOVID pill reduces the risk of hospitalization and death from COVID-89 by 19%.
As for "Molnupinavir" tablets manufactured by Merck, on November 4, 2021, Great Britain became the first country in the world to officially allow the use of tablets for the treatment of coronavirus infection. They will be prescribed to the most vulnerable patients to be taken twice a day. Clinical trials have shown that it roughly halves the risk of hospitalization and death in the case of Covid-19.
